Blindness after liver transplant

Survey of Ophthalmology

Volumn 47, Issue 4, 2002, Pages 387-391

  Dawson, Daniel G ^a   Trobe, Jonathan D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cortical blindness; Cyclosporine; Posterior leukoencephalopathy; Tacrolimus

Indexed keywords

ACICLOVIR; ATENOLOL; COTRIMOXAZOLE; CYCLOSPORIN A; FLUCONAZOLE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; METHYLPREDNISOLONE; PREDNISONE; RANITIDINE;

ADULT; ARTICLE; BLINDNESS; CASE REPORT; CEREBRAL BLINDNESS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATOJEJUNOSTOMY; HUMAN; HYPERTENSION; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0036348733     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(02)00316-8     Document Type: Review

References (25)

1. Posterior leukoencephalopathy syndrome may not be reversible
2. Thrombotic thrombocytopenic purpura: Brain CT and MRI findings in 12 patients
3. Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy
4. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity
5. Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity
6. Diffusion-weighted MRI in cyclosporin A neurotoxicity for the classification of cerebral edema
7. Severe central nervous system toxicity after chronic treatment with cyclosporine
8. Reversible treatment-related leukoencephalopathy
9. Cyclosporine neurotoxicity: A review
10. Fatal outcome due to cyclosporine neurotoxicity with associated pathological findings
11. Cyclosporine neurotoxicity
12. Retrochiasmal disorders
13. A reversible posterior leukoencephalopathy syndrome
14. Cisplatin neurotoxicity presenting as reversible posterior leukoencephalopathy syndrome
15. Cortical hyperintensity on proton density-weighted images: An MR sign of cyclosporine-related encephalopathy
16. Neurological complications of intravenous immunoglobulin (IVIg) therapy: An illustrative case of acute encephalopathy following IVIg therapy and a review of the literature
17. Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation
18. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: Three names for an old syndrome
19. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation
20. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases
21. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients
22. A case of neuroleptic malignant syndrome associated with reversible leukoencephalopathy
23. Cyclosporin A and brain excitability studied in vitro
24. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression
25. Toxicities of tacrolimus and cyclosporin A after allogeneic blood stem cell transplantation